ArticleJournal of inherited metabolic disease2021

A pilot study of neonatal GALT gene replacement using AAV9 dramatically lowers galactose metabolites in blood, liver, and brain and minimizes cataracts in GALT-null rat pups.

Shauna A Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.